I received this book for free from in exchange for an honest review. This does not affect my opinion of the book or the content of my review.
Off The Scales by Aimee Donnellan
Published by St. Martin's Press on November 18, 2025
Genres: Weight Loss Diets (Books), Sociological Study of Medicine, Diet Therapy
Pages: 320
Buy on Amazon
The inside story of the creation of Ozempic and its revolutionary impact on public health.
A “cure” for obesity has long been the holy grail for the pharmaceutical industry, one that seemed unattainable until recent breakthroughs in type 2 diabetes research led to the development of Ozempic, a weight loss medication that activates a hormone in the stomach called GLP-1, making people feel fuller for longer. The treatment is so effective that it is already disrupting many industries―from healthcare to fast food to fashion―and it has quickly made its creator, Denmark’s Novo Nordisk, the most valuable company in Europe. But the impact of GLP-1s goes far beyond billion-dollar profits; a true long-term cure for obesity could save 40 percent of American adults from dangerous, preventable illnesses. And as more potential benefits emerge, one question looms in the minds of investors, healthcare workers, and politicians: Are these drugs too good to be true?
In Off the Scales, Reuters journalist Aimee Donnellan illuminates the history of a medical breakthrough that is poised to change the world, while raising difficult social questions about inequality and morality. Through original reporting and rigorous research, she forecasts the future of GLP-1s and examines what their explosive popularity tells us about our ideals of beauty and the lengths to which people will go in order to become thin.
Along the way, Donnellan profiles the scientist whose contributions to the discovery of GLP-1 were overlooked, documents her fight for recognition while her colleagues were thrust into the limelight, and offers new insights into the ways that the food and beauty industries made billions while promoting unhealthy and unrealistic body image standards and accelerating the obesity crisis. She also provides firsthand accounts of several early Ozempic users and the transformative effect the drug has had on their weight loss journeys.
Off the Scales is an informative and entertaining study of the unexpected consequences of finally getting what we’ve wanted for so long.
Off the Scales by Aimee Donnellan takes a thoughtful look at Ozempic and the growing use of GLP 1 medications, placing them within the bigger picture of health, weight, and society. Donnellan’s measured approach stands out in a field where opinions are often polarized. She shows that this drug is not simply a miracle cure or just a warning, but a complex medical advance shaped by years of research and different interests.
The book’s main strength is how it links science to real-life effects. Donnellan looks at how a drug made for diabetes has quickly changed public health debates, the food industry, and how people think about bodies. She points out ethical issues like access, cost, and long-term use, but avoids using fear or hype. By sharing patient stories and the experience of a scientist who was often ignored, she adds emotional and moral depth without taking advantage of anyone’s struggles.
The book’s main weakness is in its conclusions. Donnellan brings up key questions about inequality, profit, and social pressure, but often does not go further with deeper analysis or clear suggestions for the future. This careful approach keeps the book balanced, but some readers might wish for more critical discussion or firmer opinions.
Overall, Off the Scales is a thoughtful and informative book for anyone who wants to understand Ozempic beyond the headlines. It treats the topic with care and encourages readers to think, not judge.
Reviewed by: Orsayor
